{"name":"Tarsa Therapeutics","permalink":"tarsa-therapeutics","crunchbase_url":"http://www.crunchbase.com/company/tarsa-therapeutics","homepage_url":"http://www.tarsatherapeutics.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2009,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"267-273-7940","description":"Oral formulation of Calcitonin","created_at":"Wed Jan 20 07:35:50 UTC 2010","updated_at":"Fri Mar 16 13:53:20 UTC 2012","overview":"<p>Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.</p>","image":{"available_sizes":[[[150,80],"assets/images/resized/0007/4051/74051v1-max-150x150.jpg"],[[250,134],"assets/images/resized/0007/4051/74051v1-max-250x250.jpg"],[[345,186],"assets/images/resized/0007/4051/74051v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"President, Founder & Chief Executive Officer, Director","person":{"first_name":"David","last_name":"Brand","permalink":"david-brand","image":null}},{"is_past":false,"title":"Founder & Chief Scientific Officer","person":{"first_name":"James","last_name":"Gilligan","permalink":"james-gilligan","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$76.5M","funding_rounds":[{"round_code":"a","source_url":"http://onbiovc.com/tarsa-therapeutics-inc-series-a-24m/","source_description":"Tarsa Therapeutics, Inc.: Series A $24M","raised_amount":24000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":17,"investments":[{"company":null,"financial_org":{"name":"MVM Life Science Partners","permalink":"mvm-life-science-partners","image":{"available_sizes":[[[150,88],"assets/images/resized/0006/8440/68440v1-max-150x150.jpg"],[[166,98],"assets/images/resized/0006/8440/68440v1-max-250x250.jpg"],[[166,98],"assets/images/resized/0006/8440/68440v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Quaker BioVentures","permalink":"quaker-bioventures","image":{"available_sizes":[[[139,90],"assets/images/resized/0004/9249/49249v1-max-150x150.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-250x250.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Novo Ventures","permalink":"novo-ventures","image":{"available_sizes":[[[133,56],"assets/images/resized/0004/6080/46080v2-max-150x150.jpg"],[[133,56],"assets/images/resized/0004/6080/46080v2-max-250x250.jpg"],[[133,56],"assets/images/resized/0004/6080/46080v2-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/tarsa-therapeutics-adds-245m-financing-advances-osteoporosis-drug/2011-07-12?utm_medium=rss&utm_source=rss","source_description":"Tarsa Therapeutics adds to $24.5M financing, advances osteoporosis drug","raised_amount":24500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":12,"investments":[]},{"round_code":"b","source_url":"http://www.prnewswire.com/news-releases/tarsa-therapeutics-completes-28-million-series-b-financing-to-advance-ostora-oral-calcitonin-142908965.html","source_description":"Tarsa Therapeutics Completes $28 Million Series B Financing to Advance OSTORAâ„¢ Oral Calcitonin","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":3,"funded_day":16,"investments":[{"company":null,"financial_org":{"name":"Foresite Capital","permalink":"foresite-capital","image":{"available_sizes":[[[150,52],"assets/images/resized/0018/4163/184163v1-max-150x150.jpg"],[[238,83],"assets/images/resized/0018/4163/184163v1-max-250x250.jpg"],[[238,83],"assets/images/resized/0018/4163/184163v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Novo A/S","permalink":"novo-a-s","image":null},"person":null},{"company":null,"financial_org":{"name":"MVM Life Science Partners","permalink":"mvm-life-science-partners","image":{"available_sizes":[[[150,88],"assets/images/resized/0006/8440/68440v1-max-150x150.jpg"],[[166,98],"assets/images/resized/0006/8440/68440v1-max-250x250.jpg"],[[166,98],"assets/images/resized/0006/8440/68440v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Quaker BioVentures","permalink":"quaker-bioventures","image":{"available_sizes":[[[139,90],"assets/images/resized/0004/9249/49249v1-max-150x150.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-250x250.jpg"],[[139,90],"assets/images/resized/0004/9249/49249v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"8 Penn Center, 1628 John F. Kennedy Boulevard","address2":"Suite 1400","zip_code":"19103-2124","city":"Philadelphia","state_code":"PA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,99],"assets/images/resized/0017/9172/179172v1-max-150x150.jpg"],[[250,166],"assets/images/resized/0017/9172/179172v1-max-250x250.jpg"],[[450,299],"assets/images/resized/0017/9172/179172v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}